
AI News
Bristol Myers Squibb upgrades to Nvidia’s Vera Rubin AI architecture
Bristol Myers Squibb is set to become the first life sciences company to deploy Nvidia’s DGX SuperPOD based on the advanced Vera Rubin architecture. The pharmaceutical giant plans to integrate this high-performance computing cluster to accelerate drug discovery, protein modeling, and large-molecule development across its global research facilities.














.jpg)







